These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 33269637)

  • 1. Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications.
    Siafaka PI; Özcan Bülbül E; Dilsiz P; Karantas ID; Okur ME; Üstündağ Okur N
    J Drug Target; 2021 Jun; 29(5):476-490. PubMed ID: 33269637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.
    Ali A; Sheikh IA; Mirza Z; Gan SH; Kamal MA; Abuzenadah AM; Damanhouri GA; Ashraf GM
    Curr Drug Metab; 2015; 16(5):376-88. PubMed ID: 25495738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug loading and release from electrospun biodegradable nanofibers.
    Goonoo N; Bhaw-Luximon A; Jhurry D
    J Biomed Nanotechnol; 2014 Sep; 10(9):2173-99. PubMed ID: 25992453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.
    Pehlivan SB
    Pharm Res; 2013 Oct; 30(10):2499-511. PubMed ID: 23959851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
    Spuch C; Saida O; Navarro C
    Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-driven Microemulsion Based Intranasal Delivery to Neurotechnology-driven Neuralink: Strategies to Improve Management of Neurodegenerative Disorders.
    Pragya ; Bisht S; Parashar P
    AAPS PharmSciTech; 2024 Sep; 25(7):215. PubMed ID: 39266806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic application of electrospun nanofibrous meshes.
    Kim HS; Yoo HS
    Nanomedicine (Lond); 2014 Apr; 9(4):517-33. PubMed ID: 24787440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
    Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
    J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.
    Weydt P; La Spada AR
    Expert Opin Ther Targets; 2006 Aug; 10(4):505-13. PubMed ID: 16848688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
    Lee J; Boo JH; Ryu H
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1316-23. PubMed ID: 19716395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology: Its Application in Treating Neurodegenerative Diseases.
    Naz F; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(1):34-53. PubMed ID: 32938356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun nanofibers as versatile platform in antimicrobial delivery: current state and perspectives.
    Maleki Dizaj S; Sharifi S; Jahangiri A
    Pharm Dev Technol; 2019 Dec; 24(10):1187-1199. PubMed ID: 31424308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain drug delivery systems for neurodegenerative disorders.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2388-402. PubMed ID: 23016644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.